This is a preview of subscription content, log in via an institution to check access.
Notes
2014 Canadian dollars
Reference
Khoudigian-Sinani S, et al. The premarket assessment of the cost-effectiveness of a predictive technology "Straticyte" for the early detection of oral cancer: a decision analytic model. Health Economics Review 7: No. 35, 2 Oct 2017. Available from: URL: https://doi.org/10.1186/s13561-017-0170-6
Rights and permissions
About this article
Cite this article
Straticyte potentially cost effective for identifying risk of oral cancer. PharmacoEcon Outcomes News 789, 28 (2017). https://doi.org/10.1007/s40274-017-4435-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4435-4